-Define marketing strategy through the implementation of cross functional brand plan-Lead cross functional team in order to guarantee the effective deployment and monitoring of brand plan tactics-Ensure implementation of omnichannel communication strategy-Collaborate with Customer Value Manager team in implementing bespoke local and country projects aimed to improve the patient journey-Analyse market data and identify key segment drivers, growth opportunities and business threats-Enhance the engagement with stakeholder groups-Underterstand financials and forecasting to provide inputs to financial process and business review-Understand of expense budget planning and tracking

- Definition and cross-functional development of the Brand Plan- Launch of new drug dosage- Implementation of the omnichannel strategy- Project management of Customer Value Manager team- Organization of events and congresses- Analysis of sales data, KPIs and performance

- Definition, implementation and follow-up of Luxturna and Ilaris Brand Plan in Italy-Localization of project designed by Region Europe-Implementation of omnichannel strategy- Management of internal approval processes for promotional materials and sponsorship projects-Supporting Field Force cycle meetings-Digital Marketing-Organization of congresses with different providers

-Sales and market trends analysis-Competitive Analysis and critical understanding of market-Creating and editing products technical specification sheets-Delivering trainings to sales force about products portfolio-Development communication materials collaborating with Medical, Regulatory and Sales Department-Supporting the senior brand manager with promotional activities and communication strategy-Ad hoc activities on different therapeutic areas-Relationship with KOLs-Supporting with events and congresses organization

I examinated  renal injury and alterations of neurobehavioral outcome in preterm and intrauterine growth restricted newborns

I studied: 1) the role of Regulatory T Lymphocytes in tumors and human autoimmune diseases; 2) how better characterize and quantifying Tumor-Infiltrating Lymphocytes in order to improve predictivity of cancer prognosis and to tailoring the treatment with immune checkpoint inhibitors, in the precision medicine perspective